IceCure Medical (ICCM) Equity Ratio (2020 - 2025)

IceCure Medical (ICCM) has 6 years of Equity Ratio data on file, last reported at 0.65 in Q4 2025.

• Quarterly Equity Ratio rose 18.76% year-over-year to 0.65 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.65 (up 18.76% YoY) and the FY2025 annual result came in at 0.65, up 18.76% from the prior year.
• Equity Ratio grew to 0.65 in Q4 2025 per ICCM's latest filing, from 0.55 in the prior quarter.
• Across five years, Equity Ratio topped out at 0.84 in Q4 2022 and bottomed at 0.55 in Q4 2024.
• The 5-year median for Equity Ratio is 0.74 (2023), against an average of 0.72.
• The widest annual swing landed in 2021, when Equity Ratio soared 51.39%; it then decreased 25.96% in 2024.
• Tracing ICCM's Equity Ratio over 5 years: stood at 0.84 in 2021, then advanced by 0.84% to 0.84 in 2022, then declined by 11.98% to 0.74 in 2023, then slipped by 25.96% to 0.55 in 2024, then grew by 18.76% to 0.65 in 2025.
• Per Business Quant, the three latest ICCM Equity Ratio figures stand at 0.65 (Q4 2025), 0.55 (Q4 2024), and 0.74 (Q4 2023).

Peer Comparison